GRIN1 and breast carcinoma: GRIN1 or NMDAR1 (N-Methyl-D-Aspartate Receptor Subunit NR1) was shown to be expressed in breast cancer specimens, but not in normal breast and to be involved in tumor growth [31], being thus, a potential oncogene.